These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

185 related articles for article (PubMed ID: 3106370)

  • 41. Direct binding of thyrotropin receptor autoantibody to in vitro translated thyrotropin receptor: a comparison to radioreceptor assay and thyroid stimulating bioassay.
    Morgenthaler NG; Hodak K; Seissler J; Steinbrenner H; Pampel I; Gupta M; McGregor AM; Scherbaum WA; Banga JP
    Thyroid; 1999 May; 9(5):466-75. PubMed ID: 10365678
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Heterogeneity in cellular and antibody responses against thyrotropin receptor in patients with Graves' disease detected using synthetic peptides.
    Fan JL; Desai RK; Seetharamaiah GS; Dallas JS; Wagle NM; Prabhakar BS
    J Autoimmun; 1993 Dec; 6(6):799-808. PubMed ID: 7512341
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Acute pre-tibial myxoedema following radioiodine therapy for thyrotoxic Graves' disease.
    Harvey RD; Metcalfe RA; Morteo C; Furmaniak W; Weetman AP; Bevan JS
    Clin Endocrinol (Oxf); 1995 Jun; 42(6):657-60; discussion 661. PubMed ID: 7634509
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Pretibial myxedema.
    Chung-Leddon J
    Dermatol Online J; 2001 Feb; 7(1):18. PubMed ID: 11328639
    [No Abstract]   [Full Text] [Related]  

  • 45. [Evolution of diagnostic and therapeutic criteria in Graves' disease in Spain. Comparison of the results of 2 surveys in 1987 and 1995].
    Escobar Jiménez F; Luna López V; Fernández Soto ML; Quezada Charneco M; Glinoer D
    Med Clin (Barc); 1998 Sep; 111(6):205-10. PubMed ID: 9789225
    [TBL] [Abstract][Full Text] [Related]  

  • 46. [Hypothyroidism and endocrine orbitopathy].
    Wiesli P; Knierim M; Knierim C; Schmid C
    Praxis (Bern 1994); 2000 Oct; 89(40):1612-5. PubMed ID: 11081360
    [TBL] [Abstract][Full Text] [Related]  

  • 47. The diagnostic value of antibody tests in Graves' ophthalmopathy.
    Kendall-Taylor P; Jones D; Weightman D; Atkinson S
    Dev Ophthalmol; 1989; 20():51-7. PubMed ID: 2687054
    [No Abstract]   [Full Text] [Related]  

  • 48. Graves' disease presenting as localized myxedema in a thigh donor graft site.
    Missner SC; Ramsay EW; Houck HE; Kauffman CL
    J Am Acad Dermatol; 1998 Nov; 39(5 Pt 2):846-9. PubMed ID: 9810913
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Patient with plaques on lower extremities and systemic symptoms.
    Bloomquist L; Cho S
    Am Fam Physician; 2011 Nov; 84(10):1157-9. PubMed ID: 22085671
    [No Abstract]   [Full Text] [Related]  

  • 50. [Pretibial myxoedema in Graves' disease].
    Tomás-Velázquez A; Panadero Meseguer P; Aguado L
    Aten Primaria; 2019 Dec; 51(10):654-655. PubMed ID: 30846307
    [No Abstract]   [Full Text] [Related]  

  • 51. [Pretibial myxedema (infiltrative dermopathy) in a patient with Basedow's disease].
    Zbranca E; Petrescu Z; Măndăşescu S; Rusu M; Bîrsu M; Petrescu G
    Rev Med Chir Soc Med Nat Iasi; 1983; 87(2):303-6. PubMed ID: 6689539
    [No Abstract]   [Full Text] [Related]  

  • 52. Ophthalmopathy of Graves' disease: a comparison between patients treated surgically and patients treated with radioiodide.
    Hamilton RD; Mayberry WE; McConahey WM; Hanson KC
    Mayo Clin Proc; 1967 Dec; 42(12):812-8. PubMed ID: 5630560
    [No Abstract]   [Full Text] [Related]  

  • 53. [EMO syndrome].
    Shimura H; Endo T; Kobayashi T
    Nihon Rinsho; 2006 May; Suppl 1():311-5. PubMed ID: 16776152
    [No Abstract]   [Full Text] [Related]  

  • 54. Graves' dermopathy: responsive with intralesion steroid.
    Tarigan TJ; Rihatmadja R; Hutabarat E
    Acta Med Indones; 2014 Apr; 46(2):148-9. PubMed ID: 25053689
    [No Abstract]   [Full Text] [Related]  

  • 55. Pretibial myxedema.
    Patil MM; Kamalanathan S; Sahoo J; Rajesh NG
    QJM; 2015 Dec; 108(12):985. PubMed ID: 26231090
    [No Abstract]   [Full Text] [Related]  

  • 56. [Thyroid dysfunctions as autoimmune diseases].
    Nagataki S; Yokoyama N
    Nihon Naika Gakkai Zasshi; 1997 Mar; 86(3):391-4. PubMed ID: 9198617
    [No Abstract]   [Full Text] [Related]  

  • 57. Immunogenetic markers in patients with Graves' disease.
    Schifferdecker E; Kühnl P; Schöffling K; Manfras B; Holzberger G; Spielmann W; Böhm BO
    Klin Wochenschr; 1991 Apr; 69(6):256-60. PubMed ID: 2038175
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Graves' disease: clinical correlation with autoantibody activity.
    Valente WA
    Md Med J; 1988 Nov; 37(11):866-9. PubMed ID: 3054388
    [No Abstract]   [Full Text] [Related]  

  • 59. The clinical immunology of Graves' ophthalmopathy.
    Sergott RC; Felberg NT; Savino PJ; Blizzard JJ; Schatz NJ
    Ophthalmology; 1981 Jun; 88(6):484-7. PubMed ID: 6973736
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Graves' disease.
    Nat Rev Dis Primers; 2020 Jul; 6(1):53. PubMed ID: 32616715
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.